ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

ClinicalTrials.gov ID: NCT02389946

Public ClinicalTrials.gov record NCT02389946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 12:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - V

Study identification

NCT ID
NCT02389946
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Biotronik, Inc.
Industry
Enrollment
1,334 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2015
Primary completion
Mar 31, 2017
Completion
Feb 28, 2021
Last update posted
Aug 2, 2022

2015 – 2021

United States locations

U.S. sites
55
U.S. states
25
U.S. cities
52
Facility City State ZIP Site status
Not listed Fairhope Alabama 36535
Not listed Concord California 94520
Not listed La Mesa California 91942
Not listed Laguna Hills California 92653
Not listed Mission Viejo California 92691
Not listed Washington D.C. District of Columbia 20010
Not listed Clearwater Florida 33756
Not listed Hollywood Florida 33021
Not listed Orlando Florida 32803
Not listed Tampa Florida 33613
Not listed Atlanta Georgia 30309
Not listed Urbana Illinois 61801
Not listed Fort Wayne Indiana 46845
Not listed Baltimore Maryland 21218
Not listed Boston Massachusetts 02120
Not listed Bay City Michigan 48708
Not listed Detroit Michigan 48236
Not listed Lansing Michigan 48912
Not listed Pontiac Michigan 48341
Not listed Rochester Michigan 48307
Not listed Troy Michigan 48085
Not listed Ypsilanti Michigan 48197
Not listed Minneapolis Minnesota 55407
Not listed Omaha Nebraska 68124
Not listed Hackensack New Jersey 07601
Not listed Neptune City New Jersey 07753
Not listed Newark New Jersey 07102
Not listed New York New York 10021
Not listed New York New York 10029
Not listed New York New York 10032
Not listed Asheville North Carolina 28803
Not listed Greensboro North Carolina 27401
Not listed Fargo North Dakota 58102
Not listed Cincinnati Ohio 45219
Not listed Cleveland Ohio 44111
Not listed Columbus Ohio 43210
Not listed Elyria Ohio 44035
Not listed Toledo Ohio 43606
Not listed Toledo Ohio 43608
Not listed Portland Oregon 97225
Not listed Butler Pennsylvania 16001
Not listed Mechanicsburg Pennsylvania 17050
Not listed Wynnewood Pennsylvania 19096
Not listed York Pennsylvania 17403
Not listed Providence Rhode Island 02906
Not listed Greenville South Carolina 29605
Not listed Rock Hill South Carolina 29732
Not listed Knoxville Tennessee 37934
Not listed Dallas Texas 75226
Not listed Houston Texas 77030
Not listed McKinney Texas 75069
Not listed Tyler Texas 75701
Not listed Charlottesville Virginia 22908
Not listed Virginia Beach Virginia 23454
Not listed Charleston West Virginia 25304

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02389946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2022 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02389946 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →